Filtros de búsqueda

Lista de obras de

(Immuno)proteasomes as therapeutic target in acute leukemia

artículo científico publicado en 2017

18F-FDG or 3'-deoxy-3'-18F-fluorothymidine to detect transformation of follicular lymphoma

artículo científico publicado en 2015

18F‐fluoro‐deoxyglucose positron emission tomography in assessment of myeloma‐related bone disease: A systematic review ⬇️

artículo científico publicado el 15 de abril de 2012

89Zr-Immuno-PET: Toward a Noninvasive Clinical Tool to Measure Target Engagement of Therapeutic Antibodies In Vivo

artículo científico publicado en 2019

A Rational Strategy for Reducing On-Target Off-Tumor Effects of CD38-Chimeric Antigen Receptors by Affinity Optimization.

artículo científico publicado en 2017

A clinical update on the role of carfilzomib in the treatment of relapsed or refractory multiple myeloma

artículo científico publicado en 2016

A novel mutation in a Turkish patient with Hermansky-Pudlak syndrome type 5

artículo científico publicado en 2007

A phase 2 multicentre study of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with relapsed or refractory multiple myeloma

artículo científico publicado en 2013

A phase II study of vorinostat (MK-0683) in patients with polycythaemia vera and essential thrombocythaemia.

artículo científico publicado en 2013

A population-based study on different regimens of R-CHOP in patients with newly diagnosed DLBCL in The Netherlands

artículo científico publicado en 2020

A prospective longitudinal study on rotation thromboelastometry in women with uncomplicated pregnancies and postpartum ⬇️

artículo científico publicado el 31 de diciembre de 2012

A question of class: Treatment options for patients with relapsed and/or refractory multiple myeloma ⬇️

artículo científico publicado en 2017

A randomized phase 3 study on the effect of thalidomide combined with adriamycin, dexamethasone, and high-dose melphalan, followed by thalidomide maintenance in patients with multiple myeloma

artículo científico publicado en 2009

Adherence and patients' experiences with the use of oral anticancer agents.

artículo científico publicado en 2013

Age and aging in blood disorders: multiple myeloma

artículo científico publicado en 2014

Age and organ damage correlate with poor survival in myeloma patients: meta-analysis of 1435 individual patient data from 4 randomized trials

artículo científico publicado en 2013

Alemtuzumab for refractory celiac disease

artículo científico publicado en 2006

Allogeneic transplantation after reduced-intensity conditioning with fludarabine-CY for both indolent and aggressive lymphoid malignancies

artículo científico publicado en 2014

An European Myeloma Network recommendation on tools for diagnosis and monitoring of multiple myeloma: what to use and when

scholarly article by Jo Caers et al published 31 August 2018 in Haematologica

An immunocompromised man with a fever

artículo científico publicado el 1 de enero de 2011

Analysis of efficacy and prognostic factors of lenalidomide treatment as part of a Dutch compassionate use program

artículo científico publicado en 2010

Analysis of the efficacy and toxicity of bortezomib for treatment of relapsed or refractory multiple myeloma in community practice.

artículo científico publicado en 2005

Anti-leukemic activity and mechanisms underlying resistance to the novel immunoproteasome inhibitor PR-924

artículo científico publicado en 2014

Antileukemic activity and mechanism of drug resistance to the marine Salinispora tropica proteasome inhibitor salinosporamide A (Marizomib). ⬇️

artículo científico publicado en 2014

Antiplatelet therapy versus observation in low-risk essential thrombocythemia with a CALR mutation.

artículo científico publicado en 2016

Approach to the Older Adult With Multiple Myeloma

artículo científico publicado en 2019

Associations between gender, disease features and symptom burden in patients with myeloproliferative neoplasms: an analysis by the MPN QOL International Working Group

artículo científico publicado en 2016

Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95):

scientific article published on 30 April 2020

Bone marrow stromal proteoglycans regulate megakaryocytic differentiation of human progenitor cells

artículo científico publicado en 2004

Bortezomib before and after autologous stem cell transplantation overcomes the negative prognostic impact of renal impairment in newly diagnosed multiple myeloma: a subgroup analysis from the HOVON-65/GMMG-HD4 trial

artículo científico publicado en 2013

Bortezomib before and after high-dose therapy in myeloma: long-term results from the phase III HOVON-65/GMMG-HD4 trial.

artículo científico publicado en 2017

Bortezomib induction and maintenance treatment in patients with newly diagnosed multiple myeloma: results of the randomized phase III HOVON-65/ GMMG-HD4 trial

artículo científico publicado en 2012

Bortezomib resistance in multiple myeloma is associated with increased serine synthesis.

artículo científico publicado en 2017

Bortezomib, melphalan, prednisone (VMP) versus melphalan, prednisone, thalidomide (MPT) in elderly newly diagnosed multiple myeloma patients: A retrospective case-matched study

scientific article published on 05 February 2014

Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study

scientific article published on 03 June 2019

Bortezomib-based induction followed by stem cell transplantation in light chain amyloidosis: results of the multicenter HOVON 104 trial

artículo científico publicado en 2019

CD38 as a therapeutic target for adult acute myeloid leukemia and T-cell acute lymphoblastic leukemia

artículo científico publicado en 2018

CD38 expression and complement inhibitors affect response and resistance to daratumumab therapy in myeloma

artículo científico publicado en 2016

CD38 knockout natural killer cells expressing an affinity optimized CD38 chimeric antigen receptor successfully target acute myeloid leukemia with reduced effector cell fratricide

artículo científico publicado en 2020

CD38-targeted therapy with daratumumab reduces autoantibody levels in multiple myeloma patients

artículo científico publicado en 2019

CD38-targeting antibodies in multiple myeloma: mechanisms of action and clinical experience

artículo científico publicado en 2018

Carfilzomib Combined With Thalidomide and Low-dose Dexamethasone for Remission Induction and Consolidation in Newly Diagnosed Transplant Eligible Patients With Multiple Myeloma: 8 vs 4 Induction Cycles; the Carthadex Trial

scientific article published on 12 August 2020

Carfilzomib for relapsed and refractory multiple myeloma

Caring for older adults with multiple myeloma during the COVID-19 Pandemic: Perspective from the International Forum for Optimizing Care of Older Adults with Myeloma

scientific article published on 17 April 2020

Catastrophic antiphospholipid syndrome in the obstetric period ⬇️

artículo científico publicado el 24 de octubre de 2011

Central nervous system involvement by multiple myeloma: A multi-institutional retrospective study of 172 patients in daily clinical practice.

artículo científico publicado en 2016

Cereblon loss and up-regulation of c-Myc are associated with lenalidomide resistance in multiple myeloma patients

scientific article published on 15 March 2018

Chemotherapeutic treatment of bone marrow stromal cells strongly affects their protective effect on acute myeloid leukemia cell survival

artículo científico publicado en 2008

Circulating YKL-40 in patients with essential thrombocythemia and polycythemia vera treated with the novel histone deacetylase inhibitor vorinostat

artículo científico publicado en 2014

Combined CD28 and 4-1BB Costimulation Potentiates Affinity-tuned Chimeric Antigen Receptor-engineered T Cells

artículo científico publicado en 2019

Comparison of modern and conventional imaging techniques in establishing multiple myeloma-related bone disease: a systematic review

artículo científico publicado en 2013

Cost-effectiveness of rituximab as maintenance treatment for relapsed follicular lymphoma: results of a population-based study.

artículo científico publicado en 2014

Current and New Therapeutic Strategies for Relapsed and Refractory Multiple Myeloma: An Update.

artículo científico publicado en 2017

Current multiple myeloma treatment strategies with novel agents: a European perspective

scientific article published on 19 January 2010

Cutaneous involvement in multiple myeloma: a multi-institutional retrospective study of 53 patients.

artículo científico publicado en 2016

Cytomegalovirus Reactivation in a Patient With Extensively Pretreated Multiple Myeloma During Daratumumab Treatment

scientific article published on 13 October 2018

Defining the vulnerable patient with myeloma-a frailty position paper of the European Myeloma Network

scientific article published on 18 June 2020

Developments in continuous therapy and maintenance treatment approaches for patients with newly diagnosed multiple myeloma

scientific article published on 13 February 2020

Diagnosis, risk stratification and management of monoclonal gammopathy of undetermined significance and smoldering multiple myeloma

artículo científico publicado en 2016

Diagnosis, treatment, and response assessment in solitary plasmacytoma: updated recommendations from a European Expert Panel

artículo científico publicado en 2018

Distinct clustering of symptomatic burden among myeloproliferative neoplasm patients: retrospective assessment in 1470 patients

artículo científico publicado en 2014

Donor versus no-donor comparison of newly diagnosed myeloma patients included in the HOVON-50 multiple myeloma study

artículo científico publicado en 2012

Effect of conditioning regimens on graft failure in myelofibrosis: a retrospective analysis

artículo científico publicado en 2015

Effect of daratumumab on normal plasma cells, polyclonal immunoglobulin levels, and vaccination responses in extensively pre-treated multiple myeloma patients

artículo científico publicado en 2019

Effect of thalidomide with melphalan and prednisone on health-related quality of life (HRQoL) in elderly patients with newly diagnosed multiple myeloma: a prospective analysis in a randomized trial ⬇️

artículo científico publicado el 7 de abril de 2011

Efficacy of first-line treatments for multiple myeloma patients not eligible for stem cell transplantation: a network meta-analysis

scholarly article by Hedwig M Blommestein et al published May 2019 in Haematologica

Elderly patients with multiple myeloma: towards a frailty approach?

artículo científico publicado en 2017

Erratum to: Practical Considerations for the Use of Daratumumab, a Novel CD38 Monoclonal Antibody, in Myeloma

artículo científico publicado en 2016

European Myeloma Network guidelines for the management of multiple myeloma-related complications

artículo científico publicado en 2015

European Myeloma Network: the 3rd Trialist Forum Consensus Statement from the European experts meeting on multiple myeloma.

artículo científico publicado en 2010

European myeloma network recommendations on diagnosis and management of patients with rare plasma cell dyscrasias

artículo científico publicado en 2018

Exocytosis of polyubiquitinated proteins in bortezomib-resistant leukemia cells: a role for MARCKS in acquired resistance to proteasome inhibitors

artículo científico publicado en 2016

Exosomes Secreted by Apoptosis-Resistant Acute Myeloid Leukemia (AML) Blasts Harbor Regulatory Network Proteins Potentially Involved in Antagonism of Apoptosis

artículo científico publicado en 2016

Expert panel consensus statement on the optimal use of pomalidomide in relapsed and refractory multiple myeloma

artículo científico publicado en 2014

Extended follow up of high-dose melphalan and autologous stem cell transplantation after vincristine, doxorubicin, dexamethasone induction in amyloid light chain amyloidosis of the prospective phase II HOVON-41 study by the Dutch-Belgian Co-operativ

artículo científico publicado en 2015

Extramedullary relapses after allogeneic non-myeloablative stem cell transplantation in multiple myeloma patients do not negatively affect treatment outcome.

artículo científico publicado en 2008

Fatal intracranial haemorrhage associated with the administration of low-molecular-weight-heparin in a child

artículo científico publicado en 2005

Fedratinib in patients with myelofibrosis previously treated with ruxolitinib: An updated analysis of the JAKARTA2 study using stringent criteria for ruxolitinib failure

artículo científico publicado en 2020

Frailty in multiple myeloma: the need for harmony to prevent doing harm

artículo científico publicado en 2019

Front-line daratumumab-VTd versus standard-of-care in ASCT-eligible multiple myeloma: matching-adjusted indirect comparison

artículo científico publicado en 2020

Gene expression profiling for molecular classification of multiple myeloma in newly diagnosed patients

artículo científico publicado en 2010

Generation and characterization of CD1d-specific single-domain antibodies with distinct functional features

artículo científico publicado en 2016

Genomic amplification of MYC as double minutes in a patient with APL-like leukemia

artículo científico publicado en 2014

Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report

artículo científico publicado en 2015

Granulocyte colony-stimulating factor mobilized whole blood containing over 0.3 x 106/kg CD34+ cells is a sufficient graft in autologous transplantation for relapsed non-Hodgkin's lymphoma

artículo científico publicado en 2002

Hb Amsterdam [alpha32(B13)Met--Ile (alpha2)]: a new unstable variant associated with an alpha-thalassemia phenotype and a new African polymorphism

artículo científico publicado en 2005

Health-care professionals' perspective on discussing sexual issues in adult patients after haematopoietic cell transplantation.

artículo científico publicado en 2017

Health-related quality of life in transplant ineligible newly diagnosed multiple myeloma patients treated with either thalidomide or lenalidomide-based regimen until progression: a prospective, open-label, multicenter, randomized, phase 3 study

artículo científico publicado en 2019

High cereblon expression is associated with better survival in patients with newly diagnosed multiple myeloma treated with thalidomide maintenance.

artículo científico publicado en 2012

High stem cell frequency in acute myeloid leukemia at diagnosis predicts high minimal residual disease and poor survival

artículo científico publicado en 2005

Higher ratio immune versus constitutive proteasome level as novel indicator of sensitivity of pediatric acute leukemia cells to proteasome inhibitors

scientific article published on 20 September 2013

Highly effective mobilization of CD34 positive cells as a poor prognostic factor in acute myeloid leukemia. Possible causes and consequences

artículo científico publicado en 2013

Homing and clonogenic outgrowth of CD34(+) peripheral blood stem cells: a role for L-selectin?

artículo científico publicado en 2002

IGFBP7 Induces Differentiation and Loss of Survival of Human Acute Myeloid Leukemia Stem Cells without Affecting Normal Hematopoiesis

artículo científico publicado en 2018

Identification of L-selectin binding heparan sulfates attached to collagen type XVIII.

artículo científico publicado en 2005

Identification of a small subpopulation of candidate leukemia-initiating cells in the side population of patients with acute myeloid leukemia

scientific article published on 01 December 2008

Immune-modulatory effects of bortezomib in GVHD

scientific article published on 01 May 2007

Impact of Fc gamma receptor polymorphisms on efficacy and safety of daratumumab in relapsed/refractory multiple myeloma.

artículo científico publicado en 2018

Impaired bortezomib binding to mutant β5 subunit of the proteasome is the underlying basis for bortezomib resistance in leukemia cells.

artículo científico publicado en 2011

Implantable defibrillators in cardiac amyloidosis

artículo científico publicado en 2012

Improved survival among younger but not among older patients with Multiple Myeloma in the Netherlands, a population-based study since 1989.

artículo científico publicado en 2010

Improving survival in patients with transformed B cell non Hodgkin lymphoma: consolidation with 90Yttrium ibritumomab tiuxetan‐BEAM and autologous stem cell transplantation ⬇️

artículo científico publicado el 9 de enero de 2012

In vitro model for hematopoietic progenitor cell homing reveals endothelial heparan sulfate proteoglycans as direct adhesive ligands ⬇️

artículo científico publicado el 2 de octubre de 2003

Increased resistance to activated protein C after short-term oral hormone replacement therapy in healthy post-menopausal women

artículo científico publicado en 2002

Interferon-γ-induced upregulation of immunoproteasome subunit assembly overcomes bortezomib resistance in human hematological cell lines

artículo científico publicado en 2014

Interleukin-2 receptor alpha-chain (CD25) expression on leukaemic blasts is predictive for outcome and level of residual disease in AML.

artículo científico publicado en 2009

International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma

artículo científico publicado en 2014

Interobserver reproducibility of tumor uptake quantification with 89Zr-immuno-PET: a multicenter analysis

scientific article published on 17 June 2019

Interstitial pneumonitis caused by Pneumocystis jirovecii pneumonia (PCP) during bortezomib treatment

artículo científico publicado en 2009

Ixazomib Treatment of IgA Multiple Myeloma With Hyperviscosity Syndrome

artículo científico publicado en 2020

Ixazomib for the treatment of multiple myeloma

scientific article published on 13 November 2018

Ixazomib-Thalidomide-low dose dexamethasone induction followed by maintenance therapy with ixazomib or placebo in newly diagnosed multiple myeloma patients not eligible for autologous stem cell transplantation; results from the randomized phase II H

artículo científico publicado en 2020

Janus kinase-2 inhibitor fedratinib in patients with myelofibrosis previously treated with ruxolitinib (JAKARTA-2): a single-arm, open-label, non-randomised, phase 2, multicentre study

artículo científico publicado en 2017

Lenalidomide as maintenance treatment for patients with multiple myeloma after autologous stem cell transplantation: a pharmaco-economic assessment

scientific article published on 23 July 2020

Lenalidomide combined with low-dose cyclophosphamide and prednisone modulates Ikaros and Aiolos in lymphocytes, resulting in immunostimulatory effects in lenalidomide-refractory multiple myeloma patients

Lenalidomide maintenance after nonmyeloablative allogeneic stem cell transplantation in multiple myeloma is not feasible: results of the HOVON 76 Trial

artículo científico publicado en 2011

Letter From van Galen et al Regarding Article, “Cardiac Amyloidosis: A Treatable Disease Often Overlooked” ⬇️

artículo científico publicado el 3 de abril de 2012

Leukaemia cutis: clinical features and treatment strategies

artículo científico publicado en 2002

Leukemic stem cell frequency: a strong biomarker for clinical outcome in acute myeloid leukemia

artículo científico publicado en 2014

Long-Term Follow-Up of Tandem Autologous Stem-Cell Transplantation in Multiple Myeloma ⬇️

artículo científico publicado el 8 de noviembre de 2010

Management of patients with multiple myeloma in the era of COVID-19 pandemic: a consensus paper from the European Myeloma Network (EMN)

scientific article published on 22 May 2020

Melphalan, prednisone, and lenalidomide versus melphalan, prednisone, and thalidomide in untreated multiple myeloma

artículo científico publicado en 2016

MicroRNA signatures characterize multiple myeloma patients

artículo científico publicado en 2011

Molecular basis of resistance to proteasome inhibitors in hematological malignancies

artículo científico publicado en 2014

Monitoring of EBV reactivation is justified in patients with aplastic anemia treated with rabbit ATG as a second course of immunosuppression

artículo científico publicado en 2008

Monocytes and Granulocytes Reduce CD38 Expression Levels on Myeloma Cells in Patients Treated with Daratumumab

artículo científico publicado en 2017

Multi-center randomized open label phase II trial on three rituximab dosing schemes in immune thrombocytopenia patients

artículo científico publicado en 2014

Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

article

Myeloproliferative neoplasm (MPN) symptom assessment form total symptom score: prospective international assessment of an abbreviated symptom burden scoring system among patients with MPNs

artículo científico publicado en 2012

Nailfold capillary abnormalities in sclerodermatous chronic GVHD.

artículo científico publicado en 2013

Neonatal porencephaly and adult stroke related to mutations in collagen IV A1

article published in 2006

New drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG)

artículo científico publicado en 2014

Noise-Induced Variability of Immuno-PET with Zirconium-89-Labeled Antibodies: an Analysis Based on Count-Reduced Clinical Images

Normal hematopoietic stem cells within the AML bone marrow have a distinct and higher ALDH activity level than co-existing leukemic stem cells

artículo científico publicado en 2013

Optimizing the use of lenalidomide in relapsed or refractory multiple myeloma: consensus statement

scientific article published on 04 February 2011

Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial

artículo científico publicado en 2018

Overcoming bortezomib resistance in human B cells by anti-CD20/rituximab-mediated complement-dependent cytotoxicity and epoxyketone-based irreversible proteasome inhibitors

artículo científico publicado en 2013

Pancreatic pseudocyst in an adult patient after treatment with pegylated asparaginase ⬇️

artículo científico publicado el 14 de enero de 2011

Patient-centered practice in elderly myeloma patients: an overview and consensus from the European Myeloma Network (EMN)

Performance of 89Zr-Labeled-Rituximab-PET as an Imaging Biomarker to Assess CD20 Targeting: A Pilot Study in Patients with Relapsed/Refractory Diffuse Large B Cell Lymphoma

artículo científico publicado en 2017

Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN).

artículo científico publicado en 2011

Pharmacodynamic monitoring of (immuno)proteasome inhibition during bortezomib treatment of a critically ill patient with lupus nephritis and myocarditis

artículo científico publicado en 2015

Phase 1/2 study of lenalidomide combined with low-dose cyclophosphamide and prednisone in lenalidomide-refractory multiple myeloma

artículo científico publicado en 2016

Phase 2 study of carfilzomib, thalidomide, and dexamethasone as induction/consolidation therapy for newly diagnosed multiple myeloma

artículo científico publicado en 2014

Phase 2 study of carfilzomib, thalidomide, and low-dose dexamethasone as induction and consolidation in newly diagnosed, transplant eligible patients with multiple myeloma, the carthadex trial

scientific article published on 04 April 2019

Phase I/II clinical study of Tosedostat, an inhibitor of aminopeptidases, in patients with acute myeloid leukemia and myelodysplasia

artículo científico publicado en 2010

Phase II multicenter study of arsenic trioxide, ascorbic acid and dexamethasone in patients with relapsed or refractory multiple myeloma.

artículo científico publicado en 2006

Phase III study of the value of thalidomide added to melphalan plus prednisone in elderly patients with newly diagnosed multiple myeloma: the HOVON 49 Study

artículo científico publicado en 2010

Platelet activation during haemodialysis: comparison of cuprammonium rayon and polysulfone membranes

artículo científico publicado en 2007

Potent Preclinical Efficacy of DuoHexaBody-CD37 in B-Cell Malignancies

artículo científico publicado en 2020

Practical Considerations for the Use of Daratumumab, a Novel CD38 Monoclonal Antibody, in Myeloma

artículo científico publicado en 2016

Preclinical Activity of JNJ-7957, a Novel BCMA×CD3 Bispecific Antibody for the Treatment of Multiple Myeloma, Is Potentiated by Daratumumab

scientific article published on 22 January 2020

Preclinical Rationale for Targeting the PD-1/PD-L1 Axis in Combination with a CD38 Antibody in Multiple Myeloma and Other CD38-Positive Malignancies

artículo científico publicado en 2020

Preclinical evidence for an effective therapeutic activity of FL118, a novel survivin inhibitor, in patients with relapsed/refractory multiple myeloma

artículo científico publicado en 2020

Prevention and management of adverse events of Novel agents in multiple myeloma: A consensus of the european myeloma network

artículo científico publicado en 2017

Prevention and management of adverse events of novel agents in multiple myeloma: a consensus of the European Myeloma Network.

artículo científico publicado en 2018

Prevention, monitoring and treatment of cardiovascular adverse events in myeloma patients receiving carfilzomib A consensus paper by the European Myeloma Network and the Italian Society of Arterial Hypertension

scientific article published on 08 April 2019

Prognostic and predictive performance of R-ISS with SKY92 in older patients with multiple myeloma: the HOVON-87/NMSG-18 trial

artículo científico publicado en 2020

Prognostic factors and outcome in relapsed multiple myeloma after nonmyeloablative allo-SCT: a single center experience

artículo científico publicado en 2010

Proteasome subunit expression analysis and chemosensitivity in relapsed paediatric acute leukaemia patients receiving bortezomib-containing chemotherapy

scientific article published on 06 September 2016

Proteoglycans guide SDF-1-induced migration of hematopoietic progenitor cells.

artículo científico publicado en 2002

RNA-based FLT3-ITD allelic ratio is associated with outcome and ex vivo response to FLT3 inhibitors in pediatric AML.

artículo científico publicado en 2018

Recommendations for vaccination in multiple myeloma: a consensus of the European Myeloma Network

artículo científico publicado en 2020

Recommended patient information sheet on the impact of haematopoietic cell transplantation on sexual functioning and sexuality

artículo científico publicado en 2019

Reduced relapse rate in upfront tandem autologous/reduced-intensity allogeneic transplantation in multiple myeloma only results in borderline non-significant prolongation of progression-free but not overall survival

artículo científico publicado en 2015

Reduced supportive capacity of bone marrow stroma upon chemotherapy is mediated via changes in glycosaminoglycan profile

artículo científico

Relationship between CD34/CD38 and side population (SP) defined leukemia stem cell compartments in acute myeloid leukemia.

artículo científico publicado en 2019

Reply to: "Discussing sexuality in cancer care: towards personalized information for cancer patients and survivors"

scientific article published on 15 July 2020

Resistance Mechanisms Towards CD38-Directed Antibody Therapy in Multiple Myeloma

artículo científico publicado en 2020

Restoration of the human stem cell niche after stem cell transplantation

artículo científico publicado en 2009

Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group

artículo científico publicado en 2017

Role of magnetic resonance imaging in the management of patients with multiple myeloma: a consensus statement

artículo científico publicado en 2015

Ruxolitinib in Myelofibrosis and Baseline Thrombocytopenia in Real Life: Results in Dutch Patients and Review of the Literature

scientific article published on 15 July 2019

Safety of thalidomide in newly diagnosed elderly myeloma patients: a meta-analysis of data from individual patients in six randomized trials

artículo científico publicado en 2012

Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project

artículo científico publicado en 2022

Second primary malignancies with lenalidomide therapy for newly diagnosed myeloma: a meta-analysis of individual patient data

artículo científico publicado en 2014

Self-Reported Sexual Function in Sexually Active Male Hodgkin Lymphoma Survivors

artículo científico publicado en 2020

Shared decision-making and providing information among newly diagnosed patients with hematological malignancies and their informal caregivers: Not "one-size-fits-all".

artículo científico publicado en 2017

Simplified frailty assessment tools: are we really capturing frailty or something else?

scientific article published on 24 January 2020

Smartphone measurements of physical activity and fitness are associated with early trial discontinuation of patients in (hemato)oncology phase I/II clinical trials

artículo científico publicado en 2020

Subendothelial heparan sulfate proteoglycans become major L-selectin and monocyte chemoattractant protein-1 ligands upon renal ischemia/reperfusion

artículo científico publicado en 2007

Successful treatment of subcutaneously disseminated aspergillosis with caspofungin acetate in an allogeneic peripheral blood stem cell transplantation patient.

artículo científico publicado en 2003

Symptom burden profile in myelofibrosis patients with thrombocytopenia: Lessons and unmet needs

artículo científico publicado en 2017

Symptomatic Profiles of Patients With Polycythemia Vera: Implications of Inadequately Controlled Disease.

artículo científico publicado en 2015

T-cell redirecting bispecific antibodies targeting BCMA for the treatment of multiple myeloma

artículo científico publicado en 2020

Targeted Therapy With Immunoconjugates for Multiple Myeloma

artículo científico publicado en 2020

Thalidomide before and after autologous stem cell transplantation in recently diagnosed multiple myeloma (HOVON-50): long-term results from the phase 3, randomised controlled trial

artículo científico publicado en 2018

Thalidomide in induction treatment increases the very good partial response rate before and after high-dose therapy in previously untreated multiple myeloma

artículo científico publicado en 2008

The adverse prognosis for acute myeloid leukemia patients with superior autologous stem cell mobilization ⬇️

artículo científico publicado el 29 de agosto de 2012

The characteristics, treatment patterns, and outcomes of older adults aged 80 and over with multiple myeloma

artículo científico publicado en 2020

The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network

artículo científico publicado en 2014

The first case of Hb Groene Hart [alpha119(H2)Pro-->Ser, CCT-->TCT (alpha1)] homozygosity confirms that a thalassemia phenotype is associated with this abnormal hemoglobin variant

artículo científico publicado en 2007

The need for information among patients with hematological malignancies: Psychometric analyses of the 62-item Hematology Information Needs Questionnaire (HINQ-62)

artículo científico publicado en 2018

The novel AML stem cell associated antigen CLL-1 aids in discrimination between normal and leukemic stem cells

artículo científico publicado en 2007

Transplant-ineligible newly diagnosed multiple myeloma: Current and future approaches to clinical care: A Young International Society of Geriatric Oncology Review Paper

artículo científico publicado en 2020

Treatment and relative survival in very elderly patients with DLBCL in The Netherlands: a population-based study, 1989 to 2015

scientific article published on 22 September 2017

Trends in incidence, treatment and survival of aggressive B-cell lymphoma in the Netherlands 1989-2010

artículo científico publicado en 2014

Uncommon lineage switch warrants immunophenotyping even in relapsing leukemia

scientific article published on 20 January 2009

Validation of the FIRST simplified frailty scale using the ECOG performance status instead of patient-reported activities

scientific article published on 22 January 2020

Whole-body low-dose computed tomography and advanced imaging techniques for multiple myeloma bone disease

artículo científico publicado en 2014

[Volume replenishment in haemorrhage: caution advised]

artículo científico publicado en 2011

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda